multipl
sclerosi
ms
chronic
demyelin
disord
unknown
etiolog
possibl
caus
viru
virustrigg
immunopatholog
viru
might
reactiv
year
latenc
lyse
oligodendrocyt
progress
multifoc
leukoencephalopathi
initi
immunopatholog
demyelin
anim
infect
theiler
murin
encephalomyel
viru
coronavirus
argument
viral
caus
ms
support
epidemiolog
analys
studi
ms
ident
twin
indic
diseas
acquir
howev
import
evid
presenc
band
oligoclon
igg
ocb
ms
brain
csf
persist
throughout
lifetim
patient
ocb
found
almost
exclus
infecti
cn
disord
antigen
target
ocb
repres
agent
caus
diseas
author
review
past
attempt
identifi
infecti
agent
ms
brain
cell
discuss
promis
use
recombin
antibodi
gener
clonal
expand
plasma
cell
brain
csf
identifi
diseaserelev
antigen
show
strategi
use
success
analyz
antigen
specif
subacut
scleros
panenceph
chronic
enceph
caus
measl
viru
neuromyel
optica
chronic
autoimmun
demyelin
diseas
produc
antibodi
direct
water
channel
multipl
sclerosi
ms
highli
disabl
chronic
neurolog
diseas
approxim
american
affect
result
death
per
year
estim
annual
morbid
cost
billion
patient
young
adult
diseas
begin
age
year
relapsingremit
cours
although
substanti
proport
patient
develop
chronic
progress
diseas
patholog
hallmark
ms
plaqu
area
white
matter
demyelin
often
inflammatori
activ
plaqu
consist
mononuclear
cell
infiltr
concentr
perivascular
space
compos
cell
b
lymphocyt
plasma
cell
macrophag
demyelin
wide
consid
product
immunemedi
patholog
cell
promot
cn
inflammatori
respons
myelin
destruct
may
also
occur
absenc
lymphocyt
infiltr
suggest
role
endogen
glia
microglia
astrocyt
sourc
injuri
mediat
barnett
prinea
igg
present
primarili
peripheri
plaqu
fig
although
role
unknown
igg
could
antibodi
infecti
agent
base
deposit
activ
complement
ms
plaqu
antibodi
could
immunopatholog
articl
discuss
evid
viral
caus
ms
describ
featur
persist
viru
infect
brain
summar
virusinduc
demyelin
human
anim
also
review
previou
attempt
identifi
infecti
agent
ms
brain
cell
well
promis
strategi
toward
goal
base
use
recombin
antibodi
rab
prepar
clonal
expand
plasma
cell
brain
csf
patient
chronic
cn
diseas
inde
success
use
rab
deriv
patient
subacut
scleros
panenceph
sspe
chronic
enceph
caus
measl
viru
mv
patient
neuromyel
optica
nmo
chronic
autoimmun
demyelin
diseas
produc
antibodi
direct
water
channel
provid
proof
principl
reagent
serv
identifi
antigen
specif
diseas
reveal
molecular
immunolog
featur
similar
ms
final
discuss
new
strategi
technolog
use
peptid
bioinformat
identifi
antigen
ms
caus
ms
unknown
like
trigger
viru
base
evid
studi
varieti
field
epidemiolog
analysi
ms
case
faro
island
indic
pointsourc
epidem
probabl
introduc
british
troop
baggag
kurtzk
hyllest
studi
ident
twin
discord
ms
shown
twin
develop
diseas
suggest
put
suscept
genom
determin
diseas
spielman
nathanson
similarli
mous
model
demyelin
produc
theiler
murin
encephalomyel
viru
tmev
genet
compon
critic
diseas
suscept
exampl
tmev
infect
produc
demyelin
sjlj
mice
mice
recent
analysi
mrna
transcriptom
epigenom
sequenc
lymphocyt
three
set
msdiscord
monozygot
twin
reveal
reproduc
differ
explain
diseas
discord
baranzini
other
furthermor
genet
disord
brain
csf
contain
oligoclon
igg
ocb
therefor
high
risk
ms
sibl
twin
like
reflect
viru
infect
superimpos
suscept
genet
background
indirect
evid
viru
may
caus
ms
come
associ
acut
viru
infect
encephalomyel
multifoc
demyelin
diseas
complic
vaccinia
smallpox
vaccin
demyelin
diseas
also
occur
patient
primari
mv
infect
acut
dissemin
encephalomyel
smallpox
vaccin
measl
uncommon
smallpox
vaccin
discontinu
children
immun
mv
today
trigger
case
acut
dissemin
encephalomyel
unknown
mechan
diseas
although
postul
immun
mediat
remain
unproven
import
clue
understand
caus
ms
provid
lifelong
presenc
patient
ocb
elev
igg
proport
csf
protein
compar
normal
human
csf
ig
predomin
igg
k
unlik
heterogen
distribut
polyclon
ig
observ
normal
csf
resolv
discret
igg
band
separ
isoelectr
focus
gel
electrophoresi
link
laurenzi
ocb
csf
detect
ms
patient
remain
sensit
laboratori
test
support
clinic
diagnosi
chronic
cn
infecti
disord
neurosyphili
tubercul
mening
fungal
mening
sspe
ocb
antibodi
direct
agent
caus
diseas
classic
articl
vandvik
other
demonstr
nearli
oligoclon
igg
sspe
csf
brain
direct
mv
follow
demonstr
ocb
csf
patient
cryptococc
mening
antibodi
direct
cryptococc
antigen
porter
other
oligoclon
igg
antibodi
csf
patient
neurosyphili
direct
treponema
palladium
vartdal
other
tabl
list
multipl
cn
diseas
human
two
exampl
demyelin
produc
experiment
infect
mice
picornavirus
coronavirus
respect
oligoclon
igg
csf
direct
agent
caus
diseas
oligoclon
igg
seen
almost
exclus
cn
disord
infecti
origin
antigen
target
ocb
direct
agent
caus
diseas
like
ms
also
trigger
agent
antibodi
respons
brain
csf
direct
furthermor
antibodi
ms
might
immunopatholog
although
evid
case
chronic
cn
diseas
ocb
present
fact
substanti
evid
humor
respons
reflect
oligoclon
igg
direct
myelin
basic
protein
mbp
proteolipid
protein
plp
myelinoligodendrocyt
protein
mog
autoantigen
capabl
induc
experiment
allerg
encephalomyel
eae
exclud
possibl
howev
cellmedi
immunopatholog
viru
infect
persist
viru
infect
may
caus
chronic
neurolog
diseas
demyelin
sspe
chronic
inflammatori
diseas
gray
white
matter
elev
titer
mv
antibodi
serum
csf
paramyxoviru
nucleocapsid
identifi
affect
brain
infecti
viru
isol
brain
explant
similarli
progress
multifoc
leukoencephalopathi
pml
fatal
human
demyelin
diseas
caus
human
papovaviru
jc
infect
brain
oligodendrocyt
isol
infect
brain
cocultiv
explant
brain
cell
normal
human
fetal
brain
surprisingli
attempt
produc
infecti
model
demyelin
experiment
infect
rodent
jc
viru
fail
instead
viral
infect
led
tumor
oncogen
potenti
papovavirus
date
pml
human
demyelin
diseas
viral
caus
known
experiment
infect
mice
tmev
produc
acut
polioenceph
anim
recov
often
persist
infect
develop
demyelin
immunosuppress
resolut
acut
polioviru
enceph
abrog
late
demyelin
persist
infect
mice
indic
diseas
immun
mediat
immun
respons
direct
viru
abil
tmev
persist
macrophag
provid
potenti
mechan
demyelin
viru
liber
apoptot
macrophag
infect
oligodendrocyt
produc
lytic
infect
demyelin
fig
multipl
strain
coronavirus
also
produc
immunemedi
demyelin
pleiotrop
present
ms
research
believ
one
infecti
agent
caus
trigger
diseas
conclus
howev
may
unduli
complic
investig
aim
identifi
caus
agent
pallidum
caus
neurosyphili
good
exampl
singl
agent
capabl
produc
multipl
cn
patholog
multipl
manifest
neurosyphili
includ
diffus
parenchymat
diseas
gener
paresi
inflamm
cerebr
arteri
meningovascular
syphili
isol
diseas
optic
nerv
syphilit
optic
atrophi
lesion
restrict
posterior
root
column
tabe
dorsali
solitari
mass
lesion
syphilit
gumma
interestingli
spectrum
quit
similar
ms
basi
success
isol
mv
sspe
brain
jc
viru
pml
brain
tissu
cultur
brain
cell
ms
patient
propag
tissu
cultur
use
techniqu
employ
rescu
herp
simplex
viru
human
trigemin
warren
other
nodos
vagu
warren
other
ganglia
although
suffici
quantiti
brain
cell
obtain
patient
ms
neuron
surviv
subcultiv
tissu
cultur
wroblewska
other
altern
approach
brain
cell
cocultiv
fuse
ms
brain
cell
attempt
obtain
cytopath
effect
cpe
produc
infecti
agent
cell
fusion
use
lysolecithin
polyethylen
glycol
cell
observ
cpe
examin
immunofluoresc
bind
antibodi
direct
variou
dna
rna
virus
explant
fuse
ms
brain
cell
also
inocul
embryon
hen
egg
rodent
speci
chimpanze
addit
attempt
produc
neurolog
diseas
msspecif
agent
found
interestingli
inocul
ms
brain
mice
result
activ
endogen
mous
viru
ww
strain
tmev
produc
demyelin
wroblewska
other
furthermor
chimpanze
inocul
ms
brain
cell
develop
demyelin
diseas
rork
other
simian
cytomegaloviru
isol
brain
anim
wroblewska
other
anoth
approach
use
isol
viru
ms
brain
involv
search
pseudotyp
transvestit
viru
pseudotyp
viru
contain
genom
one
viru
protein
coat
second
viru
may
produc
cell
tissu
cultur
contain
envelop
viru
superinfect
vesicular
stomat
viru
vsv
presenc
pseudotyp
viru
readili
detect
base
small
fraction
viru
resist
antibodi
vsv
neutral
antibodi
direct
second
viru
gilden
other
ms
brain
cell
tissu
cultur
infect
vsv
harvest
cpe
appear
assay
vsv
nonneutr
fraction
howev
envelop
viru
latent
ms
brain
cell
discov
ms
sspe
antibodi
produc
intrathec
brain
csf
antibodi
sspe
brain
igg
vandvik
other
resid
antibodyproduc
cell
identifi
phenotypespecif
marker
indic
b
lymphocyt
plasmablastsplasma
cell
fig
burgoon
other
cell
like
sourc
restrict
ocb
pattern
seen
csf
serum
affect
individu
individu
b
lymphocyt
plasma
cell
isol
parenchyma
postmortem
sspe
brain
lasercaptur
microdissect
sspe
csf
fluorescenceactiv
cell
sort
fac
analysi
revers
transcript
rna
deterg
lysat
singl
plasma
cell
variabl
region
igg
sequenc
pcr
amplifi
identifi
sequenc
function
antibodi
express
collect
analyz
larg
number
cell
repres
repertoir
intrathec
igg
express
sspe
patient
obtain
burgoon
other
owen
ritchi
other
normal
two
antibodi
sequenc
ident
patient
howev
sspe
brain
csf
mani
plasma
cell
compos
clonal
expand
popul
express
close
relat
igg
igg
express
sspe
brain
csf
somat
mutat
correspond
germlin
sequenc
distinct
immun
respons
seen
serum
patient
featur
antigendriven
select
also
observ
b
lymphocyt
plasma
cell
repertoir
isol
ms
csf
owen
other
ritchi
other
studi
antigen
specif
igg
sequenc
obtain
plasma
cell
sspe
brain
express
function
igg
burgoon
other
burgoon
other
plasma
cell
repertoir
singl
sspe
brain
heavychain
variabl
region
eight
clonal
expand
plasma
cell
popul
clone
mammalian
express
vector
alreadi
contain
appropri
constant
region
leader
sequenc
need
synthes
intact
heavi
chain
correspond
light
chain
identifi
sspe
plasma
cell
also
clone
mammalian
express
vector
cotransfect
heavi
light
chain
mammalian
cell
intact
human
igg
synthes
secret
cultur
medium
monoclon
rab
purifi
analysi
eight
rab
clonal
expand
plasma
cell
popul
reveal
five
react
specif
nucleocapsid
protein
mv
caus
diseas
rab
also
identifi
mv
antigen
enzymelink
immunosorb
assay
elisa
well
protein
immunoblot
immunoprecipit
immunostain
mvinfect
cell
express
flag
epitop
hopp
other
carboxyl
terminu
rab
also
show
despit
presenc
nativ
human
igg
antimv
rab
detect
correspond
antigen
sspe
brain
burgoon
other
domin
reactiv
rab
mv
nucleocapsid
protein
reflect
preval
seen
natur
mv
infect
sspe
norrbi
gollmar
lin
other
interestingli
half
rab
prepar
nonclon
igg
sequenc
defin
express
sspe
brain
react
mv
burgoon
other
moreov
rab
react
mv
antigen
current
assay
react
antigen
confirm
earlier
find
sspe
intrathec
antibodi
respons
diseas
relev
vandvik
other
success
identif
diseaserelev
mv
antigen
recombin
igg
sspe
brain
also
achiev
analysi
plasma
cell
sspe
csf
analysi
iggproduc
plasma
cell
antibodi
csf
parallel
find
sspe
brain
mv
persist
plasma
cell
fac
sort
csf
diseas
deposit
plate
igg
transcript
individu
plasma
cell
amplifi
sequenc
multipl
assay
reveal
rab
produc
four
expand
clone
react
either
mv
fusion
nucleocapsid
protein
owen
ritchi
other
confirm
earlier
report
humor
respons
sspe
csf
diseas
relev
griffin
enhanc
strategi
identifi
ms
antigen
rab
prepar
clonal
expand
popul
sspe
brain
use
biopan
phagedisplay
random
peptid
librari
map
correspond
mv
protein
epitop
demonstr
peptid
sequenc
select
pan
use
identifi
target
antigen
rab
databas
search
owen
other
four
rab
react
strongli
mv
antigen
biopan
commerci
phagedisplay
librari
random
peptid
phage
bound
rab
elut
amplifi
reappli
sspe
rab
success
round
pan
three
round
pan
bound
phage
examin
one
specif
peptid
sequenc
enrich
pan
experi
bound
specif
pan
rab
subsequ
elisa
assay
align
peptid
sequenc
enrich
sspe
rab
reveal
core
amino
acid
motif
peptid
search
viral
mammalian
nation
center
biotechnolog
inform
ncbi
databas
use
consensu
peptid
sequenc
obtain
two
rab
reveal
sever
homolog
restrict
search
viral
protein
sequenc
nonredund
databas
identifi
precis
epitop
mv
nucleocapsid
protein
specif
confirm
earlier
studi
sspe
igg
rab
biopan
phagedisplay
cdna
express
librari
construct
sspe
brain
burgoon
other
applic
biopan
strategi
igg
rab
identifi
ms
patient
rand
other
yu
gilden
other
discuss
later
review
varicella
zoster
viru
vzv
ubiquit
exclus
human
highli
neurotrop
herpesviru
childhood
infect
virtual
univers
primari
infect
produc
varicella
chickenpox
vzv
becom
latent
ganglion
neuron
along
entir
neuraxi
thu
vzv
reason
candid
ms
viru
detect
vzv
dna
csf
peripher
blood
mononuclear
cell
mnc
ms
patient
ordonez
other
mancuso
other
sotelo
other
suggest
link
vzv
infect
ms
reinforc
presenc
herpesvirion
vzv
dna
csf
peripher
blood
mnc
within
one
week
exacerb
patient
relapsingremit
ms
sotelo
other
analysi
csf
four
ms
patient
obtain
within
eight
day
exacerb
one
patient
obtain
remiss
three
patient
clinic
isol
syndrom
ci
high
risk
develop
ms
six
patient
infecti
neurolog
diseas
oind
burgoon
other
reveal
herpesviru
particl
csf
patient
use
electron
microscop
quantit
pcr
techniqu
describ
sotello
other
herpesvirion
readili
identifi
similarli
prepar
supernat
vzvinfect
cell
tissu
cultur
furthermor
pcr
detect
vzv
genom
csf
ms
ci
five
six
oind
patient
dna
extract
acut
plaqu
two
ms
patient
contrast
use
primer
three
distinct
region
vzv
genom
amplifi
vzv
dna
csf
patient
vzv
radiculomyel
supernat
vzvinfect
cell
tissu
cultur
furthermor
analysi
antibodi
respons
ms
patient
reactiv
vzv
show
csf
igg
ms
patient
three
eight
oind
vzv
posit
elisa
antibodi
sever
csf
success
immunoblot
vzv
sargsyan
other
find
measur
vzv
activ
surpris
ms
csf
contain
antibodi
multipl
ubiquit
virus
vzv
epsteinbarr
viru
ebv
rubella
forghani
other
importantli
none
rab
prepar
clonal
expand
plasma
cell
ms
csf
recogn
vzv
multipl
immunoassay
indic
intrathec
synthes
oligoclon
igg
ms
csf
direct
vzvspecif
protein
like
vzv
adult
seroposit
capsid
antigen
common
herpesviru
ebv
epidemiolog
studi
reveal
increas
risk
ms
ebvseroposit
individu
ascherio
munch
ascherio
other
serum
csf
ms
patient
show
enhanc
immunoreact
ebvspecif
protein
ms
patient
small
fraction
csf
oligoclon
igg
remov
incub
purifi
protein
cepok
zhou
other
recent
latent
lytic
ebv
transcript
detect
ms
nonm
inflammatori
control
brain
aloisi
colleagu
report
b
lymphocyt
activ
chronic
activ
ms
perivascular
white
matter
lesion
braininfiltr
plasma
cell
ms
patient
infect
ebv
serafini
other
result
contrast
earlier
find
sander
other
postmortem
brain
sampl
ms
patient
control
pcr
detect
ebv
dna
ms
patient
compar
control
herpesvirus
detect
frequent
includ
herp
simplex
viru
ms
patient
vs
control
ms
patient
vs
control
vzv
ms
patient
vs
control
find
statist
signific
sander
other
conclud
etiolog
associ
ms
herpesvirus
test
recent
serafini
other
detect
ebv
latenc
transcript
latent
membran
protein
ebv
nuclear
antigen
lasermicrodissect
brain
sampl
nine
case
secondari
progress
ms
well
b
cellactiv
factor
baff
acut
ms
lesion
ectop
b
cell
follicl
baff
play
role
b
cell
matur
surviv
detect
cytoplasm
immun
cell
infiltr
mening
six
ms
brain
sampl
express
baff
variabl
proport
ebvinfect
b
cell
found
mening
infiltr
ectop
b
cell
follicl
ms
brain
suggest
play
role
dysregul
ebvinfect
b
cell
togeth
presenc
infiltr
cytotox
cell
newer
find
promot
associ
ebv
ms
led
hypothesi
immun
respons
activ
ms
lesion
may
secondari
activ
ebv
infect
studi
ebv
ms
brain
role
ms
humor
respons
ebv
diseas
analyz
b
lymphocyt
plasma
cell
ms
brain
csf
ebvspecif
rna
perform
immunolog
assay
ebv
antigen
sargsyan
other
realtim
quantit
pcr
detect
abund
ebv
transcript
latent
infect
cell
posit
control
ebvinfect
cell
five
ebvinfect
hodgkin
b
cell
lymphoma
b
lymphocyt
plasma
cell
csf
ms
patient
nonm
inflammatori
cn
diseas
control
analysi
plaqu
ms
patient
contain
perivascular
cuff
b
lymphocyt
patient
whose
plaqu
report
abund
ebv
serafini
other
reveal
none
four
ebv
transcript
basi
previou
studi
sander
other
report
detect
ebv
dna
approxim
ms
plaqu
also
examin
five
lesion
revers
transcript
realtim
pcr
lymphoma
control
posit
ebv
transcript
although
confirm
presenc
abund
latenc
transcript
three
ms
brain
lesion
previous
report
posit
ebv
dna
detect
ebvspecif
transcript
ms
plaqu
sargsyan
other
coincid
studi
willi
other
employ
situ
hybrid
immunohistochemistri
realtim
pcr
also
fail
detect
ebv
cohort
ms
specimen
contain
plaqu
heterogen
b
cell
infiltr
willi
studi
also
use
realtim
pcr
examin
separ
collect
ms
specimen
includ
b
cell
infiltr
mening
parenchym
b
cell
aggreg
detect
ebv
low
level
ms
mening
specimen
rare
detect
ebv
ms
plaqu
agre
publish
studi
ebv
ms
brain
includ
report
higher
percentag
ebvposit
sampl
among
nonneurolog
diseas
brain
parkinson
diseas
brain
compar
ms
alzheim
brain
sander
other
anoth
studi
compar
presenc
ebv
ms
lesion
normalappear
white
matter
control
brain
tissu
opsahl
kennedi
detect
low
level
latent
lytic
ebv
transcript
three
group
tissu
situ
hybrid
ebv
lytic
latent
protein
immunohistochem
stain
tissu
group
qualit
statist
signific
quantit
differ
ms
lesion
either
normalappear
white
matter
control
brain
tissu
detect
final
peferoen
other
examin
brain
specimen
ms
patient
includ
patient
younger
year
old
thu
includ
earlyonset
diseas
along
tissu
block
patient
identifi
ebv
posit
serafini
other
situ
hybrid
reveal
nuclear
ebv
rna
one
tissu
sampl
singl
ms
patient
although
b
cell
follicl
identifi
ms
specimen
b
cellrich
area
detect
examin
situ
hybrid
immunohistochem
stain
ebv
viral
lytic
latent
protein
although
posit
control
ebvassoci
tumor
includ
cn
lymphoma
posit
hybrid
ebvencod
rna
ms
sampl
neg
nuclear
ebv
rna
except
one
tissu
specimen
singl
ms
patient
ms
specimen
also
neg
ebv
immunohistochemistri
except
singl
specimen
neg
ebv
rna
stain
multipl
ebv
lytic
protein
marker
realtim
reversetranscript
pcr
detect
ebv
genom
rna
five
tissu
block
b
cellrich
area
three
ms
patient
show
ebv
dna
rna
control
ebvassoci
tumor
ebvtransform
cell
line
jy
ms
sampl
analysi
pair
csf
serum
sampl
ms
patient
reveal
igg
indic
ms
csf
nonm
cn
inflammatori
diseas
control
csf
indic
intrathec
synthesi
total
igg
sargsyan
other
howev
intrathec
synthesi
antiebv
igg
antibodi
differ
significantli
ms
patient
nonm
cn
inflammatori
diseas
control
also
test
whether
rab
gener
clonal
expand
ms
csf
plasma
cell
bound
ebv
antigen
indic
diseas
relev
sargsyan
other
although
ebvinfect
cell
readili
stain
control
antibodi
ms
csf
none
rab
prepar
clonal
expand
plasma
cell
popul
csf
four
patient
relaps
progress
ms
bound
ebvinfect
cell
immunolog
find
support
specif
intrathec
antiebv
antibodi
respons
ms
nmo
demyelin
disord
predilect
optic
nerv
spinal
cord
nmo
ms
share
overlap
clinic
laboratori
radiolog
histopatholog
featur
nosolog
distinct
nmo
ms
subject
much
debat
lennon
other
uniqu
associ
nmoigg
nmo
spectrum
disord
suggest
humor
immun
respons
might
directli
mediat
diseas
pathogenesi
test
hypothesi
gener
rab
clonal
expand
csf
plasma
cell
patient
nmo
bennett
other
six
rab
react
rab
induc
complementmedi
cytox
antibodydepend
cellular
cytotox
cell
line
addit
use
rat
mbp
eae
model
show
inject
rab
reactiv
rat
produc
patholog
chang
prototyp
nmothat
perivascular
demyelin
human
ig
deposit
complement
activ
polymorphonuclear
granulocyt
infiltr
axon
transect
fig
wherea
human
rab
mvspecif
rab
produc
cn
immunopatholog
bennett
other
similar
find
obtain
infus
nmo
serum
igg
rat
eae
model
bradl
other
kinoshita
other
intracerebr
inject
serum
nmoigg
human
complement
murin
brain
saadoun
other
togeth
experi
document
direct
contribut
autoantibodi
nmo
patholog
overlap
clinic
patholog
featur
nmo
ms
well
likelihood
ms
viru
trigger
rais
possibl
infecti
agent
might
trigger
autoimmun
respons
nmo
patient
rab
technolog
current
use
identifi
target
epitop
water
channel
protein
seroposit
nmo
patient
compar
known
viral
sequenc
identif
novel
target
humor
immun
respons
seroposit
seroneg
nmo
patient
also
pursu
humor
immun
respons
nmo
may
result
molecular
mimicri
epitop
spread
primari
infect
cn
astrocyt
full
character
immun
respons
earli
recurr
nmo
may
identifi
infecti
associ
consist
biochem
marker
diseas
ms
intrathec
synthesi
ig
reflect
presenc
ocb
multipl
line
circumstanti
experiment
evid
suggest
b
cell
andor
antibodi
product
contribut
ms
diseas
patholog
activ
ms
lesion
autopsi
specimen
compos
mix
popul
b
cell
character
deposit
immunoglobulin
receptor
termin
activ
complement
associ
macrophag
activ
plaqu
margin
luchinetti
other
breij
other
b
lymphocyt
infiltr
cn
level
intrathec
igg
synthesi
correl
diseas
sever
parenchym
inflamm
cepok
rosch
other
antib
cell
therapi
rituxan
efficaci
relapsingremit
ms
patient
hauser
other
precis
role
b
cell
diseas
present
unknown
could
involv
antigen
present
pathogen
cell
product
proinflammatori
cytokin
synthesi
antibodi
unknown
virus
autoantigen
promot
oligodendrocyt
loss
tissu
destruct
defin
primari
antigen
intrathec
oligoclon
igg
respons
ms
problemat
interpret
multipl
studi
confound
larg
array
antibodi
specif
infecti
agent
variou
myelin
autoantigen
detect
csf
serum
studi
antibodi
bind
specif
antigen
found
fraction
ms
patient
sampl
often
present
control
csf
correspond
promin
ocb
thu
presum
absenc
specif
antigen
respons
broad
humor
reactiv
observ
ms
csf
serum
led
view
b
cell
activ
ms
epiphenomenon
gener
nonsens
respons
secondari
diseas
pathogenesi
nonsens
antibodi
respons
observ
ms
csf
may
consequ
longterm
chronic
inflamm
experiment
studi
secondari
immun
human
defin
antigen
result
polyclon
bystand
activ
unrel
longliv
memori
b
cell
proport
rel
abund
bernasconi
other
thu
background
nonsens
b
cell
respons
ms
might
expect
consid
ongo
inflamm
crucial
question
whether
promin
intrathec
ocb
ms
antibodi
diseaserelev
antigen
normal
physiolog
condit
lymphocyt
cell
monocyt
b
lymphocyt
found
csf
contrast
csf
patient
ms
isol
optic
neuriti
contain
significantli
increas
number
classswitch
memori
b
cell
antibodysecret
cell
cepok
other
corcion
other
haubold
other
provid
potenti
restrict
diseasespecif
popul
cell
investig
ms
intrathec
igg
respons
primari
antibodysecret
cell
csf
shortliv
plasma
blast
high
high
hladr
high
detect
throughout
cours
diseas
whose
number
correl
intrathec
igg
synthesi
cepok
rosch
other
sequenc
analys
ig
sequenc
recov
brain
csf
ms
patient
repeatedli
identifi
overrepres
clonal
relat
igg
variabl
v
region
sequenc
owen
other
qin
other
baranzini
other
colombo
other
molecular
character
oligoclon
v
region
sequenc
indic
product
postgermin
center
celldepend
respons
sequenc
extens
mutat
intraclon
sequenc
diversif
readili
evid
b
cell
clonal
expans
observ
earli
demyelin
diseas
expand
b
lymphocyt
plasma
cell
clone
detect
csf
individu
first
clinic
attack
clinic
isol
syndrom
often
follow
rapid
convers
clinic
definit
ms
haubold
other
qin
other
other
use
nonbias
rtpcr
protocol
amplifi
v
region
sequenc
singl
cell
sort
fac
individu
well
pcr
plate
ritchi
other
harp
other
owen
wing
other
v
region
sequenc
ms
patient
relapsingremit
ms
patient
primari
progress
secondari
progress
diseas
ms
patient
first
clinic
episod
cn
inflammatori
diseas
includ
sspe
chronic
mening
nmo
hiv
cn
involv
tabl
expand
plasma
blast
clone
promin
repertoir
vari
vh
sequenc
analyz
number
clone
observ
repertoir
part
depend
number
function
sequenc
analyz
csf
repertoir
cell
sequenc
contain
largest
number
clone
align
v
region
sequenc
homolog
germlin
segment
reveal
somat
mutat
almost
vh
sequenc
averag
degre
somat
mutat
uniqu
v
j
rearrang
ms
inflammatori
csf
repertoir
similar
rang
homolog
differ
repres
point
mutat
compar
observ
sequenc
analyz
ms
sspe
brain
tissu
smithjensen
other
comparison
repertoir
plasma
blast
plasma
cell
reveal
signific
sequenc
overlap
wing
other
distinguish
featur
ms
csf
repertoir
bias
use
gene
segment
gene
famili
owen
wing
other
approxim
ms
csf
plasma
blast
use
gene
segment
gene
famili
fig
bia
observ
peripher
blood
igm
peripher
blood
b
lymphocyt
sort
match
ms
match
ms
peripher
blood
memori
cell
repertoir
indic
target
activ
plasma
blast
ms
csf
repertori
bia
also
found
chronic
mening
csf
repertoir
csf
repertoir
sspe
statist
bias
famili
gene
segment
csf
repertoir
nmo
patient
two
hiv
patient
neurolog
involv
thu
global
bia
observ
ms
csf
plasma
cell
explain
increas
lifetim
preferenti
recruit
cn
memori
b
cell
express
gene
segment
instead
cn
inflammatori
diseas
repertoir
reveal
uniqu
vh
famili
bias
like
mold
induc
antigen
examin
vh
repertoir
subject
clinic
isol
demyelin
syndrom
bennett
other
repertoir
subject
demonstr
bias
use
famili
gene
segment
csf
plasma
cell
b
lymphocyt
repertoir
one
patient
demonstr
bia
clinic
subject
csf
igg
repertoir
bia
rapidli
progress
definit
ms
wherea
individu
without
repertoir
bia
develop
ms
minimum
year
followup
p
furthermor
detail
analys
identifi
uniqu
v
region
antibodi
gene
mutat
pattern
signatur
ms
csf
b
cell
predict
convers
ms
accuraci
small
cohort
patient
clinic
isol
syndrom
cameron
other
advantag
singlecel
pcr
abil
produc
rab
duplic
vivo
pair
heavyand
lightchain
v
region
product
larg
array
rab
domin
plasma
blast
clone
like
encompass
major
specif
ms
csf
ocb
base
direct
link
expand
ms
csf
igg
clonal
popul
specif
ocb
establish
use
proteom
obermei
other
ocb
excis
gel
trypsin
peptid
fragment
separ
sequenc
mass
spectrometri
identifi
highli
specif
peptid
sequenc
align
uniqu
pattern
v
region
somat
mutat
almost
vh
vk
clonal
popul
amplifi
match
ms
csf
valid
util
cnsderiv
rab
antigen
identif
rab
produc
plasma
cell
recov
brain
csf
patient
sspe
ms
cn
inflammatori
diseas
b
lymphocyt
clonal
expans
promin
sspe
csf
brain
rab
deriv
plasma
cell
clone
bound
either
mv
nucleocapsid
fusion
protein
burgoon
other
owen
ritchi
other
produc
csfderiv
bival
human
rab
patient
relapsingremit
ms
includ
csf
obtain
initi
clinic
event
primaryand
relapsingprogress
ms
patient
owen
other
addit
control
human
hu
chimer
rab
gener
antimyelin
hybridoma
direct
myelin
protein
mbp
plp
mog
murin
v
region
sequenc
fuse
human
constant
c
region
mbp
plp
mog
induc
eae
protein
thought
repres
promin
autoantigen
ms
antimbp
antimog
antibodi
respons
analyz
extens
discord
result
regard
antibodi
preval
ms
serum
csf
berger
other
kuhl
other
thu
ms
csfderiv
ab
extens
assay
bind
myelin
protein
immunostain
reliabl
assay
identif
conform
epitop
mog
mbp
plp
overexpress
hek
cell
assay
bind
control
hu
chimer
ms
rab
wherea
chimer
hu
rab
readili
duplic
antigen
specif
parent
hybridoma
demonstr
specif
stain
mogtransfect
cell
hu
mog
rab
fig
none
ms
csfderiv
rab
produc
laboratori
react
cell
express
mog
mbp
plp
absenc
specif
myelin
protein
parallel
result
use
sensit
solutionphas
immunoassay
detect
high
b
cell
epitop
antigen
determin
recogn
antibodi
ultim
produc
stimul
b
cell
singl
antigen
protein
usual
contain
multipl
epitop
two
type
epitop
recogn
antibodi
linear
form
continu
sequenc
amino
acid
protein
conform
compos
amino
acid
discontinu
primari
sequenc
brought
togeth
protein
fold
linear
epitop
identifi
screen
combinatori
synthet
peptid
librari
express
librari
deriv
organ
tissu
conform
epitop
identifi
xray
crystallograph
studi
antigenantibodi
complex
mimotop
epitopemimick
structur
hirabayashi
other
peptid
sequenc
differ
origin
antigen
sequenc
mimotop
mimic
linear
conform
epitop
felici
other
potent
tool
gather
inform
b
cell
epitop
riemer
other
phagedisplay
random
peptid
librari
technolog
repres
novel
approach
identifi
epitopemimotop
specif
highaffin
phage
clone
enrich
affin
select
monoclon
antibodi
scott
smith
librari
contain
larg
number
random
peptid
allow
identif
rare
epitop
detect
convent
method
technolog
use
determin
target
sequenc
monoclon
antibodi
recogn
linear
conform
epitop
combinatori
approach
allow
select
ligand
unbias
function
assay
without
preconcept
natur
target
diseas
mintz
other
phagedisplay
random
peptid
librari
success
identifi
rheumatoid
factorspecif
mimotop
zhang
davidson
map
neutral
antibodi
puumala
hantaviru
heiskanen
other
hiv
antigen
ferrer
other
coronavirusspecif
epitop
zhong
other
linear
circular
phagedisplay
peptid
librari
commerci
avail
circular
librari
contain
display
peptid
structur
constrain
disulfid
loop
allow
product
bind
conform
higher
affin
sequenc
express
linear
librari
success
use
ms
rab
select
highaffin
phage
peptid
pan
phagedisplay
random
peptid
librari
basic
pan
protocol
identifi
specif
peptid
target
antibodi
involv
incub
peptid
librari
individu
antibodi
coat
onto
well
reactibind
protein
plate
pierc
rockford
il
wash
away
unbound
phage
elut
specif
bound
phage
low
ph
buffer
glycin
ph
elut
phage
titer
amplifi
midlog
growth
escherichia
coli
er
cell
taken
addit
bindingamplif
cycl
enrich
specif
bind
peptid
two
three
round
individu
clone
character
posit
phage
peptid
identifi
dna
sequenc
fig
antibodi
fail
select
posit
phage
peptid
three
round
pan
fourth
fifth
pan
usual
perform
use
ultrafast
pan
method
recent
develop
lab
yu
other
method
use
phage
amplifi
midlog
grow
e
coli
minut
presenc
select
antibodi
subsequ
pan
without
phage
purif
obviat
need
tradit
largescal
amplif
purif
brief
e
coli
infectionamplif
step
yield
suffici
phage
subsequ
round
pan
within
one
day
compar
six
day
requir
tradit
pan
also
develop
streamlin
protocol
determin
phage
peptid
specif
affin
select
fig
briefli
individu
phage
plaqu
second
third
pan
amplifi
highthroughput
deepwel
plate
nunc
rochest
ny
reactiv
pan
antibodi
determin
singlepoint
elisa
use
crude
phage
cultur
without
purif
yu
owen
other
potenti
posit
clone
largescal
amplifi
confirm
dosedepend
elisa
dna
posit
phage
clone
purifi
sequenc
sever
independ
assay
routin
perform
lab
determin
phage
peptid
specif
affin
includ
dosedepend
elisa
competit
inhibit
assay
immunoblot
yu
gilden
other
select
antibodi
limit
replac
like
ms
csf
highli
sensit
techniqu
term
phagemedi
realtim
immunopcr
ipcr
use
yu
other
ipcr
antibodi
csf
sera
ms
rab
coat
onto
well
elisa
plate
phage
peptid
ad
incub
wash
bound
phage
lyse
phage
dna
detect
pcr
techniqu
exploit
fact
phage
particl
use
bind
antigen
dna
templat
quantit
pcr
amplif
thu
phage
ipcr
link
physic
associ
phenotyp
display
peptid
genotyp
encod
dna
within
phage
particl
demonstr
phage
ipcr
reproduc
detect
phage
particl
yu
other
bioinformat
tool
examin
phage
peptid
use
success
identifi
cognat
antigen
cytomegaloviru
kohler
other
hiv
jin
other
sompuram
other
appli
newli
develop
technolog
epitopemedi
antigen
predict
emap
accur
identifi
antigen
target
multipl
myeloma
author
reconstruct
protein
epitop
analyz
peptid
bound
strongli
compil
data
interrog
nonredund
protein
databas
close
match
human
cytomegaloviru
identifi
confirm
multipl
immunoassay
one
target
myeloma
use
approach
similar
involv
rab
clone
clonal
expand
plasma
cell
csf
patient
sspe
identifi
mv
epitop
phagedisplay
random
peptid
librari
screen
phage
peptid
librari
rab
gener
csf
patient
ms
identifi
highaffin
peptid
reactiv
pan
ms
rab
nativ
csf
igg
yu
gilden
other
short
length
peptid
amino
acid
allow
align
protein
databas
determin
correspond
protein
antigen
thu
reveal
numer
candid
target
protein
tog
maxim
chanc
select
bestfit
correspond
protein
antigen
critic
amino
acid
residu
within
peptid
determin
use
peptid
mutagenesi
substitut
analysi
peptid
perform
delin
ms
peptid
bind
supermotif
key
amino
acid
residu
use
spot
peptid
array
technolog
consensu
peptid
determin
use
motif
elucid
bioinformat
algorithm
meme
multipl
expectationmaxim
motif
elicit
follow
databas
search
increas
intrathec
igg
synthesi
reflect
ocb
common
abnorm
detect
ms
csf
combin
epidemiolog
genet
immunolog
data
presenc
persist
oligoclon
igg
ms
patient
provid
paraclin
evid
chronic
cn
infect
critic
task
identifi
specif
target
like
provid
clue
caus
diseas
demonstr
rab
gener
cn
clonal
expand
plasma
cell
sspe
nmo
direct
diseaserelev
agent
provid
proof
principl
experi
aim
defin
target
antigen
igg
produc
clonal
expand
csf
b
lymphocyt
plasma
cell
identifi
diseaserelev
target
ms
isol
potenti
infecti
caus
ms
coupl
highthroughput
techniqu
identifi
target
epitop
mimotop
provid
framework
develop
novel
prevent
therapeut
strategi
direct
immunofluoresc
dilut
antibodi
human
igg
conjug
fluorescein
isothiocyan
green
fluoresc
show
igg
deposit
junction
plaqueperiplaqu
white
matter
middl
arrow
mononuclear
cell
bottom
arrow
normal
white
matter
top
arrow
antigen
igg
multipl
sclerosi
brain
csf
direct
unknown
propos
model
theiler
viru
persist
macrophag
lead
demyelin
b
cell
plasma
cell
subacut
scleros
panenceph
sspe
multipl
sclerosi
ms
brain
frozen
section
sspe
ms
brain
stain
antibodi
antigen
brown
counterstain
hematoxylin
bar
histopatholog
section
spinal
cord
myelin
basic
proteininduc
experiment
allerg
encephalomyel
rat
transfus
rat
csf
rab
bennett
other
h
e
hematoxylineosin
stain
reveal
perivascular
vacuol
mononuclear
polymorphonuclear
infiltr
arrowhead
lfb
luxol
fast
bluepa
stain
demonstr
perivascular
demyelin
pa
macrophag
asterisk
perivascular
deposit
indic
local
complement
activ
arrowhead
gfap
glial
fibrillari
acid
protein
reveal
extens
perivascular
astrocyt
loss
associ
demyelin
asterisk
higg
human
igg
deposit
surround
region
perivascular
demyelin
arrowhead
app
amyloid
precursor
protein
stain
show
axon
transect
arrowhead
vh
famili
gene
segment
use
multipl
sclerosi
ms
csf
plasma
blast
differ
significantli
use
peripher
blood
b
lymphocyt
pan
phagedisplay
random
peptid
librari
antibodyco
well
three
major
step
includ
bind
librari
target
antibodi
wash
away
nonspecif
phage
elut
bound
phage
low
ph
buffer
three
five
round
perform
enrich
specif
phage
peptid
streamlin
protocol
determin
specif
phage
peptid
individu
phage
plaqu
second
third
pan
amplifi
deepwel
plate
first
screen
posit
pan
antibodi
use
enzymelink
immunosorb
assay
elisa
potenti
posit
clone
confirm
duplic
elisa
preimmun
human
igg
irrelev
rab
neg
control
follow
phage
dna
purif
sequenc
analysi
